Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Polynovo (PNV) Share Price & Analysis

PNV Stock Chart & Stats

A$0.91A$0.03(2.84%)
At close: 4:00 PM GMT+11
AUD 0.9AUD 1AUD 1.13 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
AUD 0.88 - AUD 0.93
52-Week Range
AUD 0.81 - AUD 1.39
Previous Close
AUD 0.88
Volume
733.50K
Average Volume (3M)
1.16M
Market Cap
AUD 625.21M
Enterprise Value
AUD 624.48M
Total Cash (Recent Filing)
AUD 35.47M
Total Debt (Recent Filing)
AUD 17.61M
Price to Earnings (P/E)
85.4
Beta
1.62
Next Earnings
Mar 02, 2027 (Est.)
EPS Estimate
0.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Commercial Growth And Adoption

Broad-based product growth and expanding hospital adoption indicate that PolyNovo is increasing penetration of its core platform. Rapid MTX uptake and a larger U.S. account base can support recurring demand, strengthen clinical familiarity, and extend the company’s commercial runway.

Profitability And Cash Generation

The move toward stronger profitability alongside positive operating and free cash flow improves PolyNovo’s ability to fund product development, market expansion, and capacity investment internally. This reduces reliance on external financing and supports more durable execution over coming periods.

Conservative Balance Sheet

Lower leverage and a materially larger equity base provide financial flexibility as PolyNovo expands manufacturing and commercial operations. A supportive balance sheet gives the company greater capacity to absorb execution variability while continuing investment in growth and innovation.

Bears Say

Margin Volatility

Profitability has improved but remains inconsistent, with lower net margin and large swings in gross margin across reporting periods. If this variability persists, it could limit earnings visibility, reduce operating leverage, and make the long-term economics of growth less predictable.

Uneven Cash Conversion

Although cash generation rebounded strongly, the uneven history and moderate conversion of profit into free cash flow show that investment and working-capital needs still absorb meaningful earnings. This may constrain internally funded expansion if cash conversion remains inconsistent.

Regulatory And Reimbursement Execution

Future commercial expansion is partly dependent on reimbursement conditions and regulatory milestones outside the company’s direct control. Delays or weaker provider payment confidence could slow outpatient adoption, postpone market access benefits, and extend the time required to realize growth investments.

Polynovo News

PNV FAQ

What was Polynovo ’s price range in the past 12 months?
Polynovo lowest share price was AU$0.81 and its highest was AU$1.39 in the past 12 months.
What is Polynovo ’s market cap?
Polynovo ’s market cap is AU$625.21M.
When is Polynovo ’s upcoming earnings report date?
Polynovo ’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 121 days.
How were Polynovo ’s earnings last quarter?
Polynovo released its earnings results on Aug 25, 2026. The company reported AU$0.012 earnings per share for the quarter, beating the consensus estimate of AU$0.008 by AU$0.004.
Is Polynovo overvalued?
According to Wall Street analysts Polynovo ’s price is currently Undervalued.
Does Polynovo pay dividends?
Polynovo does not currently pay dividends.
What is Polynovo ’s EPS estimate?
Polynovo ’s EPS estimate is 0.01.
How many shares outstanding does Polynovo have?
Polynovo has 690,843,000 shares outstanding.
What happened to Polynovo ’s price movement after its last earnings report?
Polynovo reported an EPS of AU$0.012 in its last earnings report, beating expectations of AU$0.008. Following the earnings report the stock price went down -5.189%.
Which hedge fund is a major shareholder of Polynovo ?
Currently, no hedge funds are holding shares in AU:PNV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology